140 related articles for article (PubMed ID: 32932701)
1. Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial Sepsis.
Mishra HK; Ma J; Mendez D; Hullsiek R; Pore N; Walcheck B
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932701
[TBL] [Abstract][Full Text] [Related]
2. Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells.
Mishra HK; Pore N; Michelotti EF; Walcheck B
Cancer Immunol Immunother; 2018 Sep; 67(9):1407-1416. PubMed ID: 29978334
[TBL] [Abstract][Full Text] [Related]
3. Ectodomain shedding by ADAM17 (a disintegrin and metalloproteinase 17) in canine neutrophils.
Snyder KM; McAloney CA; Montel JS; Modiano JF; Walcheck B
Vet Immunol Immunopathol; 2021 Jan; 231():110162. PubMed ID: 33264689
[TBL] [Abstract][Full Text] [Related]
4. Targeting ADAM17 in leukocytes increases neutrophil recruitment and reduces bacterial spread during polymicrobial sepsis.
Mishra HK; Johnson TJ; Seelig DM; Walcheck B
J Leukoc Biol; 2016 Nov; 100(5):999-1004. PubMed ID: 27059842
[TBL] [Abstract][Full Text] [Related]
5. Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during Sepsis.
Mishra HK; Ma J; Walcheck B
Front Cell Infect Microbiol; 2017; 7():138. PubMed ID: 28487846
[TBL] [Abstract][Full Text] [Related]
6. In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis.
Long C; Wang Y; Herrera AH; Horiuchi K; Walcheck B
J Leukoc Biol; 2010 Jun; 87(6):1097-101. PubMed ID: 20154226
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CXCR2 expression and function by a disintegrin and metalloprotease-17 (ADAM17).
Mishra HK; Long C; Bahaie NS; Walcheck B
J Leukoc Biol; 2015 Mar; 97(3):447-54. PubMed ID: 25412626
[TBL] [Abstract][Full Text] [Related]
8. ADAM17 activation in circulating neutrophils following bacterial challenge impairs their recruitment.
Long C; Hosseinkhani MR; Wang Y; Sriramarao P; Walcheck B
J Leukoc Biol; 2012 Sep; 92(3):667-72. PubMed ID: 22623356
[TBL] [Abstract][Full Text] [Related]
9. The -172 A-to-G variation in ADAM17 gene promoter region affects EGR1/ADAM17 pathway and confers susceptibility to septic mortality with sepsis-3.0 criteria.
He J; Zhao T; Liu L; Liao S; Yang S; Lu F; Hong Y; Wei N; Cheng H; Zhang W; Shao Y
Int Immunopharmacol; 2022 Jan; 102():108385. PubMed ID: 34862128
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil and Macrophage Cell Surface Colony-Stimulating Factor 1 Shed by ADAM17 Drives Mouse Macrophage Proliferation in Acute and Chronic Inflammation.
Tang J; Frey JM; Wilson CL; Moncada-Pazos A; Levet C; Freeman M; Rosenfeld ME; Stanley ER; Raines EW; Bornfeldt KE
Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29891514
[TBL] [Abstract][Full Text] [Related]
11. Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space.
Pruessmeyer J; Hess FM; Alert H; Groth E; Pasqualon T; Schwarz N; Nyamoya S; Kollert J; van der Vorst E; Donners M; Martin C; Uhlig S; Saftig P; Dreymueller D; Ludwig A
Blood; 2014 Jun; 123(26):4077-88. PubMed ID: 24833351
[TBL] [Abstract][Full Text] [Related]
12. ADAM17 protects against elastase-induced emphysema by suppressing CD62L
Suzuki S; Ishii M; Asakura T; Namkoong H; Okamori S; Yagi K; Kamata H; Kusumoto T; Kagawa S; Hegab AE; Yoda M; Horiuchi K; Hasegawa N; Betsuyaku T
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1172-L1182. PubMed ID: 32130031
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg1 improves survival in a murine model of polymicrobial sepsis by suppressing the inflammatory response and apoptosis of lymphocytes.
Zou Y; Tao T; Tian Y; Zhu J; Cao L; Deng X; Li J
J Surg Res; 2013 Aug; 183(2):760-6. PubMed ID: 23478085
[TBL] [Abstract][Full Text] [Related]
14. Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation.
Schumacher N; Schmidt S; Schwarz J; Dohr D; Lokau J; Scheller J; Garbers C; Chalaris A; Rose-John S; Rabe B
J Immunol; 2016 Nov; 197(9):3705-3715. PubMed ID: 27698010
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) improves the innate immune response and enhances survival in murine polymicrobial sepsis.
Cziupka K; Busemann A; Partecke LI; Pötschke C; Rath M; Traeger T; Koerner P; von Bernstorff W; Kessler W; Diedrich S; Weiss FU; Maier S; Bröker BM; Heidecke CD
Crit Care Med; 2010 Nov; 38(11):2169-74. PubMed ID: 20657274
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of Endothelial ADAM17 Reduces Retinal Ischemia-Reperfusion Induced Neuronal and Vascular Damage.
Gutsaeva DR; Shalaby L; Powell FL; Thounaojam MC; Abouhish H; Wetzstein SA; Jadeja RN; Kwok HF; Martin PM; Bartoli M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751103
[TBL] [Abstract][Full Text] [Related]
17. Diminished neutrophil extracellular trap (NET) formation is a novel innate immune deficiency induced by acute ethanol exposure in polymicrobial sepsis, which can be rescued by CXCL1.
Jin L; Batra S; Jeyaseelan S
PLoS Pathog; 2017 Sep; 13(9):e1006637. PubMed ID: 28922428
[TBL] [Abstract][Full Text] [Related]
18. Protective activity of anti-lipoteichoic acid monoclonal antibody in single or combination therapies in methicillin-resistant Staphylococcus aureus-induced murine sepsis models.
Ohsawa H; Baba T; Enami J; Hiramatsu K
J Infect Chemother; 2020 May; 26(5):520-522. PubMed ID: 32001173
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.
Nielsen TB; Pantapalangkoor P; Luna BM; Bruhn KW; Yan J; Dekitani K; Hsieh S; Yeshoua B; Pascual B; Vinogradov E; Hujer KM; Domitrovic TN; Bonomo RA; Russo TA; Lesczcyniecka M; Schneider T; Spellberg B
J Infect Dis; 2017 Aug; 216(4):489-501. PubMed ID: 28931235
[TBL] [Abstract][Full Text] [Related]
20. A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways.
Rios-Doria J; Sabol D; Chesebrough J; Stewart D; Xu L; Tammali R; Cheng L; Du Q; Schifferli K; Rothstein R; Leow CC; Heidbrink-Thompson J; Jin X; Gao C; Friedman J; Wilkinson B; Damschroder M; Pierce AJ; Hollingsworth RE; Tice DA; Michelotti EF
Mol Cancer Ther; 2015 Jul; 14(7):1637-49. PubMed ID: 25948294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
